Presence of β‐hCG either due to endogenous expression or by exogenous supplementation promotes tumorigenesis by inducing migration, invasion and stemness predominantly in BRCA1 mutant breast cancer cells. This evidence concerns the gene BRCA1 and breast carcinoma.